AbCellera Biologics Files Q1 2025 10-Q

Ticker: ABCL · Form: 10-Q · Filed: May 8, 2025 · CIK: 1703057

Abcellera Biologics INC. 10-Q Filing Summary
FieldDetail
CompanyAbcellera Biologics INC. (ABCL)
Form Type10-Q
Filed DateMay 8, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, biotech

TL;DR

AbCellera Q1 2025 10-Q filed. Check financials.

AI Summary

AbCellera Biologics Inc. filed its Q1 2025 10-Q report on May 8, 2025, for the period ending March 31, 2025. The company, based in Vancouver, Canada, operates in the pharmaceutical preparations sector. Key financial data and operational details for the first quarter of 2025 are presented in this filing.

Why It Matters

This filing provides investors and analysts with the latest financial performance and operational updates for AbCellera Biologics Inc. during the first quarter of 2025.

Risk Assessment

Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.

Key Numbers

Key Players & Entities

FAQ

What were AbCellera's total revenues for Q1 2025?

The filing does not explicitly state total revenues for Q1 2025 in the provided snippet, but it does reference revenue components like Research Fees and License income for the periods.

What is AbCellera's primary business sector?

AbCellera Biologics Inc. is classified under Pharmaceutical Preparations [2834].

When was this 10-Q report filed with the SEC?

This 10-Q report was filed on May 8, 2025.

What is the fiscal year end for AbCellera Biologics Inc.?

AbCellera Biologics Inc.'s fiscal year ends on December 31.

Where is AbCellera Biologics Inc. headquartered?

AbCellera Biologics Inc. is located in Vancouver, A1, with a ZIP code of V5Y 1G6.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding AbCellera Biologics Inc. (ABCL).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing